Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin nears key support at $70K amid mixed signals and resistance at $86,720.

Technical Signals
14 Oct 2026
Tokenpost
View Source
Neutral
Bitcoin nears key support at $70K amid mixed signals and resistance at $86,720.

Bitcoin is trading near the lower boundary of a rising price channel, with resistance at $86,720 and mixed momentum indicators creating uncertainty in its next move. A confirmed drop below the channel's lower boundary could lead to a decline toward $70,000, while a break above a shorter-term descending trendline might push Bitcoin back up to $86,720 and possibly higher. Momentum indicators like the daily Stochastic RSI and weekly MACD suggest caution, as they show signs of weakening upward momentum. If the rising channel holds, Bitcoin could still reach $100,000, but its ability to stay above the lower boundary and overcome resistance at $86,720 will be critical.

Bitcoin chart analysis is discussed alongside a market snapshot from Pluang as of Oct 14, 2026 16:31 WIB. Among 50 major cryptocurrencies priced on Pluang, 13 rose and 36 fell today. Notable movers include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% at Rp16,297 with a typical hold time of 85 days, and BAT (Basic Attention Token) up 10.30% at Rp3,496 with a typical hold time of 93 days and Pluang order activity showing 94% sell and 6% buy.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App